Please login to the form below

Not currently logged in
Email:
Password:

McCann Health Germany strengthens leadership team

Coincides with office move to support growth

new hires

From left to right: Guido Körfer, Effie Baoutis and Marc Henschel

Healthcare communications network McCann Health has made two key appointments to the leadership team of McCann Health Germany. 

Guido Körfer (pictured above) has been appointed as president of McCann Health Germany. He has over 20 years of experience in marketing and advertising, having worked at a number of networks and agencies.

Most recently, Körfer worked as managing director of Havas Germany.He has expertise in growing clients and scoring new business across a wide range of industries.

Also joining the team is Marc Henschel (pictured above), who has been appointed as executive creative director. He has over 20 years of experience in marketing and advertising, having worked at a number of creative agencies in Germany.

Prior to joining McCann Health, Henschel was international creative director at Red Bull’s lead agency. He started his career at Scholz & Friends Berlin, and he has won a number of national and international awards for his work.

I’m delighted to welcome Guido and Marc, two proven leaders with diverse industry experience, to our growing agency in Germany as we look to transform ourselves into a world-class health communications agency in our region and within our global network,” said Effie Baouis (pictured above), president, McCann Health West Europe.

The appointments follow McCann Health Germany’s announcement earlier this month that it had moved to a new office in Frankfurt, which will become the agency’s new headquarters for West Europe.

26th September 2019

From: Marketing

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Graphite Digital

Graphite is a digital agency which partners with globally respected pharma and healthcare organisations to create powerful digital experiences. We...

Latest intelligence

Emre Vural
Sourcing R&D innovation: why pharma companies need to evolve their business models
Recent years have seen a significant shift in drug development to specialty areas...
2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...

Infographics